Kristen Britton

Pediatrics
7600 Osler Drive, Suite 311
Towson, MD 21204

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma.

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 07, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026